ELIGIBILITY
• Undergraduate and graduate students enrolled at foreign colleges and universities
• Foreign nationality
• Academic focus aligns with Taiwan’s national key science & technology fields including humanities and social sciences
The TMU Research Internship (TRI) program is designed to immerse young talents in hands-on research experience in a dynamic and innovative environment. This program offers a unique opportunity to work alongside leading researchers in health sciences, providing participants with the practical skills, research acumen, and global perspectives needed to excel in their academic and professional pursuits.

Mentor profile
Education
Post-doctoral Researcher
Northern Regional Research Center, USDA, Illinois, USA
Ph.D. in Biochemistry and Plant Physiology
M.S. in Biochemistry and Plant Physiology
B.S. in Biology
University of Lille, France
Professional Appointments
Full Professor, Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering
Adjunct Professor, International PhD Program in Biomedical Engineering, College of Biomedical Engineering
Adjunct Professor, PhD Program in Cell Therapies and Regenerative Medicine, College of Medicine
Taipei Medical University, Taiwan
Introduction
Our lab focuses on the use of human platelet derived trophic factors preparation, including platelet lysates and platelet extracellular vesicles for applications in the fields of biotherapies, regenerative medicine and drug delivery. We have very active and productive international collaborations with research institutions at global level, including in France, Australia, and the USA. In particular, our laboratory is pioneering the development and use of human platelet-derived biotherapies for the treatment of diseases or the central nervous system. Students in the laboratory are encouraged to be pursuing double MS or PhD degree with institutions in France (ULille) and Japan (Tokyo University of Science). We welcome highly motivated students interested in doing an internship in the lab and contribute to our research activities, including through the Taiwan Experience Education Program (TEEP).
Research interests
Requirements and details
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) |

Mentor profile
Education
2005-2012 Postdoc fellow, Institute of Biomedical Sciences
Academia Sinica, Taiwan
Ph.D., The Graduate Institute of Life Sciences(GILS)
National Defense University, Taiwan
M.S. in Biology
B.S. in Biology
Fu Jen Catholic University, Taiwan
Professional Appointments
2024- Professor, The Ph.D. Program for Translational Medicine
2020- Associate Professor, International Ph.D. Program for Translational Science
Taipei Medical University, Taiwan
Introduction
Dr. Che-Chang Chang is an expert in cancer biology and translational medicine.
Dr. Che-Chang Chang’s Lab is focus on the cancer research and therapy. We use genomic and proteomics strategies to identify the cancer biomarkers and potential therapeutic targets. In addition, we perform the cellular functional assays, molecular experiments and PDOX mouse model for validation. Our goal is use translational medicine to bridge the bedside clinical question and bench basic research.
Research interests
Requirements and details

Mentor profile
Education
Ph.D., Department of Chemistry, College of Science
B.S., Department of Chemistry
Tunghai University, Taiwan
Professional Appointments
2025.08- Assistant Professor, Graduate Institute of Nanomedicine and Medical Engineering
Taipei Medical University, Taiwan
2025.03-2025.07 Postdoctoral Research Fellow
National Yang Ming Chiao Tung University, Taiwan
2023.09-2025.02 Research and Development Substitute Military Service
National Synchrotron Radiation Research Center (NSRRC), Taiwan
Introduction
I’m Prof. Chia-Che Chang. My research focuses on the synthesis and functional design of nanomaterials for catalytic applications, with in-situ characterization. I have conducted synchrotron-based experiments at the National Synchrotron Radiation Research Center (NSRRC), utilizing advanced in situ X-ray techniques to probe dynamic structural and electronic changes in nanomaterials under working conditions.
Our laboratory focuses on the rational design of nanomaterials for catalytic antibacterial applications with an emphasis on reactive oxygen species (ROS) generation. By engineering nanomaterials catalysts with optimized surface chemistry and electronic structures, forward to enhance the efficient production of ROS, such as •OH, O₂⁻, and ¹O₂, which induce oxidative damage to bacterial membranes, proteins, and nucleic acids.
Research interests
Requirements and details
Job Description
Research responsibilities will be jointly defined according to the student’s individual academic goals and in
collaboration with the supervising professor. In general, the scope of work will include literature review, data collection and management, and data analysis using statistical software such as SPSS
Preferred Intern Educational Level
BSN, MS, PhD related medical field
Skill sets or Qualities
Basic research skills and language ability
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) | More info |

Mentor profile
Education
Ph.D., Nursing
Case Western Reserve University, USA
M.S., Clinical Nursing
B.S., School of Nursing
National Yang-Ming University, Taiwan
Professional Appointments
2022.08- Professor, School of Gerontology Health Management and Long-term Care, College of Nursing
2022.07- Professor, Department of Humanities in Medicine, College of Medicine, School of Medicine
2019.01-2025.07 Dean, College of Interdisciplinary Studies
Taipei Medical University, Taiwan
Introduction
Chia-Chi Chang is currently a professor of School of Gerontology and Long-term Care at Taipei Medical University. Her research interests focus on ageing issues especially on feeding and nutrition problems among people with dementia. Chia-Chi has more than 20 years’ experiences with people with dementia and their caregivers. As a main investigator, she has participated in translation and validation of the WHO iSupport program into Traditional Chinese and build up the web-based iSupport platform in Taiwan. She has in charge of more than 30 projects and published more than 70 peer reviewed articles.
Dr.Chang is incharge of the iSupport for Dementia project in Taiwan. She has participated in translation and validation of the WHO iSupport program into Traditional Chinese and build up the web-based iSupport platform in Taiwan. In addition, recently, the main purpose of the study were dissemination and implementation of Chinese iSupport toolkits.
Research interests
Requirements and details
Job Description
Research responsibilities will be jointly defined according to the student’s individual academic goals and in
collaboration with the supervising professor. In general, the scope of work will include literature review, data collection and management, and data analysis using statistical software such as SPSS
Preferred Intern Educational Level
BSN, MS, PhD related medical field
Skill sets or Qualities
Basic research skills and language ability
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) | More info |

Mentor profile
Education
Ph.D. in Oral biology
M.S. in Oral biology
National Yang-Ming University
B.S. in Food Science
National Ilan University
Professional Appointments
2023- Assistant Professor, Graduate Institute of Metabolism and
Obesity Sciences
Taipei Medical University, Taiwan
2019-2022 Postdoctoral Fellow (CRTA), National Cancer Institute
National Institutes of Health, USA
Introduction
I am Dr. Ching-Wen Chang, honored to hold the position of Assistant Professor at the esteemed Graduate Institute of Metabolism and Obesity Sciences, Taipei Medical University. My specialization lies in intricate molecular research, primarily aimed at unveiling innovative molecular avenues to categorize tumor subtypes and unearth biomarkers crucial for early detection, accurate diagnosis, prognosis discernment, and prediction in liver diseases, including liver cancer and Nonalcoholic steatohepatitis (NASH).
Research Focus:
My pursuit in research is driven by a profound aspiration to decode the complex molecular mechanisms underlying liver diseases. By delving deep into the molecular intricacies of liver pathology, I aim to propel advancements in precision medicine, focusing on liver cancer and NASH. This endeavor is pivotal to enriching our understanding and management of liver conditions and contributing meaningful insights to the broader scientific community.
Mentorship Philosophy:
In my role as a mentor and educator, I strive to nurture and enlighten the upcoming generation of scientists by providing guidance in both wet-lab methodologies and computational biology. Leveraging my extensive research experience and knowledge, my goal is to create a conducive and enriching learning atmosphere, fostering curiosity, analytical thinking, and a profound passion for molecular research amongst my students.
Commitment to Excellence:
I derive immense satisfaction and fulfillment from imparting knowledge and wisdom, with the hope of sparking an enduring passion for discovery and research in the promising minds of the future. My unwavering commitment is to uphold and promote academic and research excellence. I hold a steadfast hope to witness my mentees unfold novel perspectives and contribute groundbreaking revelations to our cumulative knowledge of liver diseases and their molecular foundations, ultimately benefiting the global scientific realm.
The laboratory I oversee, situated within the Graduate Institute of Metabolism and Obesity Sciences, operates at the forefront of innovative research focusing on metabolism, obesity, and liver maladies, encompassing hepatocellular carcinoma and Nonalcoholic steatohepatitis (NASH). Our research environment is a nexus of relentless curiosity, pursuit of profound understanding, and a dedication to trailblazing methodologies in molecular studies.
Our ambition is to make substantial contributions to multiple scientific domains, including early detection, meticulous diagnosis, informed prognosis, and the cultivation of precise medical strategies. Our objectives are harmoniously aligned with the mission to decipher and provide new insights into the intricate molecular mechanisms underlying liver diseases.
Research interests
Requirements and details
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) | More info |

Mentor profile
Education
Ph.D., Institute of Neuroscience
National Yang Ming University, Taiwan
M.S., Graduate Institute of Linguistics
National Chengchi University, Taiwan
B.S., Department of Law, College of Law
National Taiwan University, Taiwan
Professional Appointments
2023.09- Assistant Professor, Graduate Institute of Mind Brain and Consciousness, College of Humanities and Social Sciences
Taipei Medical University, Taiwan
2021.05-2023.12 Consultant, the HRBP Digital Transformation Department
Wistron Smart Devices Corporation, Taiwan
2020.10-2022.10 Associate Research Scholar
Princeton Neuroscience Institute, USA
Introduction
Claire Hui-Chuan Chang (張惠娟) is an Assistant Professor at the Graduate Institute of Mind, Brain, and Consciousness, Taipei Medical University. She received her Ph.D. in Cognitive Neuroscience from National Yang-Ming University, with prior training in linguistics (M.A., National Chengchi University) and law (LL.B., National Taiwan University), giving her a strongly interdisciplinary background.
Before joining TMU, she conducted research at the Princeton Neuroscience Institute as a postdoctoral researcher and associate research scholar, and was a visiting fellow at Princeton University and INSERM-CEA in France. Her research focuses on human communication dynamics, narrative processing, and multi-brain neural coupling, using methods such as fMRI, EEG, and computational modeling. She has also served as a consultant for digital transformation and human-centered analytics in industry.
Aiming to reveal the mechanisms that support effective human communication, my lab studies behavioral, physiological, and neural dynamics using fMRI and EEG in ecologically valid experimental settings, including storytelling, movie viewing, hypnosis, music listening, and interactive video games.
Research interests
Our studies integrate four interrelated themes:
(1) the neural dynamics and evolutionary forces underlying the cortical hierarchy of narrative processing;
(2) dynamic multi-brain neural networks that emerge during effective communication;
(3) the role of idiosyncratic prior experience in shaping narrative processing; and
(4) the interaction between implicit and explicit mechanisms of communication.
Requirements and details
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) | More info |

Mentor profile
Education
2011~2015 PostDoc Research Fellow, Department of Biological Sciences
National University of Singapore, Singapore
Ph.D., Division of National Heart & Lung Institute, Faculty of Medicine
Imperial College London, UK
Professional Appointments
2022- Associate Professor, Graduate Institute of Biomedical Informatics
2017-2022 Assistant Professor, Graduate Institute of Biomedical Informatics
2015-2017 Assistant Professor, Ph.D. Program for Translational Medicine
Taipei Medical University, Taiwan
Introduction
Shu-Chun Chang is an Associate Professor of the Ph.D. Program for Translational Medicine, Taipei Medical University, Taiwan. Dr. Chang trained in extracellular biology and glycobiology and began work on cancer research as her PhD study in Imperial College London (IC, 2007-2011). Her PhD work aimed to investigate the role of Hedgehog Acyltransferase & Heparan Sulphate Proteoglycans (HSPGs) in Human Sonic Hedgehog (hShh) Signaling. These studies have greatly contributed to defining the functional roles of hShh interactions with HSPGs and palmitoylation of hShh in the formation of hShh multimeric complex, which enabled cancer cell therapeutics. Dr Chang continued to work in the field of Cancer Immunology/Inflammation as her Post-Doc research at the National University of Singapore (NUS, 2011-2015). Her findings clearly established the power of SAG-UPS (ubiquitin proteasome system) as a functional link between immune defense and apoptosis or immune-overactivation and tumorigenesis. SAG–UPS was proposed to be an efficient target for developing therapeutics against autoimmune diseases and cancers. Continuing from her postdoctoral research work, her current independent research focusses on: UPS, E2/E3 enzymes profiling, cancer therapeutics and anticancer strategies, the tumorigenic microenvironment, Hiltonol cocktails in anti-cancer strategies, anti-PD-L1 cancer vaccine. All of these related topics of research encompasses cancer immunomodulation, which she is being recognized internationally, as evidenced by multiple invitations from impactful journals to her to submit manuscripts to contribute her area of expertise.
Previously, Dr Chang revealed that dysregulation of the ubiquitination-proteasome system (UPS) exacerbates the tumor microenvironment and drives malignant transformation [1-3]. As the largest family of E3 ligases, the SCF E3 is involved in chronic inflammation-mediated tumorigenesis such as BRCA [4,5]. However, the underlying mechanisms and key factors through which SCF E3 ligase drives BRCA initiation and progression remain unclear. During Dr Chang’s research period in TMU (2015-current), since her research encompasses a wide array of experimental approaches (e.g. biochemical, cell & molecular techniques, molecular biophysics, computational modeling and immunochemical methods involving clinical specimens), as a Principle Investigator, Dr Chang has put together a team of collaborators and co-workers (both locally at TMU and internationally) to derive the best output and to spawn research collegiality and inculcate team-spirit. In the future, Dr Chang aim to investigate potent approaches to restrain the pro-tumorigenic microenvironment to inhibit cancer cell growth and metastasis.
Research interests
Requirements and details
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) | More info |

Mentor profile
Education
Ph.D., Center For Infectious Disease
University College London, UK
M.S., in Human Nutrition
Glasgow University, UK
B.S., Department of food Science and Technology
Chia Nan University, Taiwan
Professional Appointments
2019- Professor, School of Nutrition and Health Sciences
2018- Professor, Graduate Institute of Metabolism and Obesity Sciences
Taipei Medical University, Taiwan
Introduction
Prof. Jung-Su Chang was awarded her Master’s degree in Clinical Nutrition from the University of Glasgow in 2000 and her PhD degree from University College London (UCL), UK, in 2006. She obtained her postdoctoral training in Prof. David Haig’s Lab at the Moredun Research Institute and the Roslin Research Institute in Scotland, as well as in Prof. Dirk Haller’s Lab at the Technical University Munich, Germany. In 2011, she joined the School of Nutrition & Health Sciences at Taipei Medical University, Taiwan.
Prof. Chang has dedicated her research to obesity-related nutrition care. Obesity and anemia remain major global health concerns. It is estimated that half of obese patients with metabolic disorders have mild liver iron overload, but there are still no effective methods for treating obesity-related iron disorders.
Prof. Chang is intrigued by questions: How does obesity-related inflammation affect iron metabolism, and how does altered iron metabolism contribute to metabolic diseases and brain health? Can digital technology and artificial intelligence (AI) help us provide better nutrition care?
Currently, Prof. Jung-Su Chang’s lab consists of one postdoctoral researcher and two PhD students (one from Vietnam and one from Indonesia), along with four Taiwanese master’s students .
Research interests
Requirements and details
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) | More info |

Mentor profile
Education
Ph.D. Dental Pathology
Nihon University, Japan
M.S., Institute of Oral Rehabilitation, School of Dentistry
Doctor of Dental Surgery, School of Dentistry
Taipei Medical College, Taiwan
Professional Appointments
2016- Associate Professor, School of dentistry
2011-2016 Associate Professor, School of dentistry
Taipei Medical University, Taiwan
Introduction
Prof. Wei-Jen Chang is a professor in the School of Dentistry at Taipei Medical University and dedicated to fostering international collaboration and advancing global dental education. In addition to his teaching, he has extensive clinical experience at Shuang-Ho Hospital. Prof. Chang’s research focuses on areas that are crucial to advancing modern dentistry, including periodontology, implantology, dental biomaterials, tissue engineering, oral embryology and oral diagnostics. He aims to innovate treatments, improve clinical outcomes and develop new materials that enhance patient care in oral healthcare.
The Lab of Oral Biomedical and Signal Analysis is dedicated to advancing the field of oral health through innovative research in biomedical engineering. Our work focuses on the following key areas:
Research interests
Requirements and details

Mentor profile
Education
Ph.D., Department of Information Management
National Taiwan University, Taiwan
M.S., Department of Information Management
Chang Jung Christian University, Taiwan
B.S., Department of Information Management
Leader University, Taiwan
Professional Appointments
2025.03- Director, Graduate Institute of Data Science
Taipei Medical University, Taiwan
2023.08- Deputy Director TMU Research Center for AI in Medicine. Ph.D.
National Taiwan University, Taiwan
Introduction
Dr. Yung-Chun Chang specializes in text mining, natural language processing, and related machine learning and speech recognition technologies. He excels in applying these technologies to address various domain-specific challenges, with primary research interests spanning intelligent healthcare, bioinformatics, business intelligence, and language comprehension. In 2016, Professor Chang was honored with the Outstanding Postdoctoral Research Award from the Academia Sinica and the Doctoral Dissertation Award from the Association for Computational Linguistics. Beginning in 2017, he embarked on an academic career at Taipei Medical University, where he has authored numerous papers published in prestigious international journals and conferences, including TKDE, ACL, I&M, TM, HICSS, Bioinformatics, and JAMIA. His recent achievements in Clinical Natural Language Processing (ClinicalNLP) earned him the prestigious 2023 Future Technology Award. Furthermore, Professor Chang is passionate about teaching and has received several teaching awards. He has also guided his students to win numerous domestic and international awards, including second place in two tracks of the BioCreative 2022 International Biomedical Literature Text Mining Competition, a gold medal in the Taiwan AI EXPO competition, second place in the Coding101 competition, first place in the NTCIR FinArg 2023 competition, and the Innovation Award in the National Science Council’s Undergraduate Research Program.
Research interests
Requirements and details
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) | More info |

Mentor profile
Education
Ph.D., Institute of Computer Science and Information Engineering
National Central University, Taiwan
M.S., Institute of Information Management
Yuan Ze University, Taiwan
B.S., Department of Information Management
National Central University, Taiwan
Professional Appointments
2024.03- Director, Graduate Institute of Biomedical Informatics
2021.08- Director, Bioinformatics Center, Office of Data Science
2019- Professor, Graduate Institute of Biomedical Informatics
Taipei Medical University, Taiwan
Introduction
The primary research interests of ABI Lab encompass a range of fields, including but not limited to bioinformatics, machine learning, metagenomics, systems biology, and medical informatics. In recent years, ABI Lab has concentrated its research efforts on gene regulatory networks, deep learning, and precision medicine, among other areas of investigation. Moreover, ABI Lab places a premium on collaboration with biologists and researchers from a multitude of disciplines, with the objective of enhancing the value of cross-domain research (wet lab + dry lab). Moreover, the laboratory has allocated a significant amount of resources to the analysis of clinical data. The research is primarily concerned with the analysis of biomedical big data and the analysis of disease prognosis through the utilisation of deep learning methodologies. The research topics are original and innovative, and the research is diverse, offering both depth and clinical value. The ABI Lab has made significant contributions to the field of medical diagnosis and care research, which demonstrates the efforts and contributions of the ABI Lab in developing the value of biomedical information in interdisciplinary research. Furthermore, the ABI Lab actively promotes collaboration between biomedical information and various research areas. Furthermore, the ABI Lab has actively promoted the integration of bioinformatics with a range of research disciplines, underscoring the pivotal role of bioinformatics in cross-disciplinary research.
Research interests
Requirements and details
Job Description
This internship offers:
✔ Exposure to real-world medical AI projects
✔ Hands-on experience with healthcare big data and machine learning techniques
✔ Collaboration with healthcare professionals and data scientists
✔ Opportunities for academic publicatio
Preferred Intern Educational Level
We welcome applications from students at various academic levels:
– Undergraduate (final-year students) in Biomedical Informatics, Computer Science, Bioinformatics, Data Science, or Healthcare Management.
-Master’s and Ph.D. students in Biomedical Informatics, Artificial Intelligence, Machine Learning, Bioinformatics, or related fields.
– Postdoctoral researchers with expertise in AI, medical data analysis, or precision medicine are also encouraged to apply.
Skill sets or Qualities
Familiar with R, Python, or possessing development experience in any programming language
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) | More info |

Mentor profile
Education
Ph.D., Department of Human Nutrition and Food Management
M.S., Department of Food Science and Nutrition
The Ohio State University, USA
B.S., School of Nutrition and Health Sciences
Taipei Medical University, Taiwan
Professional Appointments
2024.02- Dean, Office of Global Engagement
2015.08- Adjunct Professor, School of Health Care Administration
2004.02- Professor, School of Nutrition and Health Sciences
Taipei Medical University, Taiwan
Introduction
Dr. Jane C.-J. Chao graduated from the Department of Human Nutrition and Food Management at The Ohio State University and obtained her Ph.D. degree in 1993. Subsequently, she received post-doctoral training in the Division of Foods and Nutrition at the University of Illinois at Urbana-Champaign from 1993 to 1994. She then returned to her alma mater Taipei Medical University to be a faculty member in the School of Nutrition and Health Sciences since 1995. She is currently the Dean of the Office of Global Engagement and a professor in the School of Nutrition and Health Sciences at Taipei Medical University. Over the past 30 years, her research primarily focuses on the effects of herbal extracts and active components on gastrointestinal diseases. She published numerous SCI journal papers and several book chapters, served as a reviewer for journals, and worked as a guest professor at the Health Sciences University of Hokkaido. She is currently a member of the American Society for Nutrition, the President of the Nutrition Society of Taiwan, and the Executive supervisor of the Chinese Taipei Association for the Study of Obesity. She has devoted herself to innovative research in herbal foods and gastrointestinal diseases continuously.
Lab 657 in the School of Nutrition and Health Sciences at Taipei Medical University (TMU) is a molecular nutrition laboratory. We currently have 15 lab members including 1 PI (me), 2 research assistants, 1 postdoc (from Malaysia), 4 doctoral students (2 from Vietnam), 3 master’s students (1 from Vietnam), and 4 professional master’s students. Among 15 lab members, there are 4 foreigners. The research in our lab mainly focuses on the effects of Lycium barbarum polysaccharides, probiotics, and postbiotics on the progression and remission of ulcerative colitis using animal and cell models with the collaboration of Prof. Tomonori Nochi at Tohoku University in Japan. Additionally, we are interested in the evaluation of functional foods on chronic diseases using animal or human studies. We have collaborated with Prof. Chyi-Huey Bai in the School of Public Health at TMU and Prof. Chien-Yeh Hsu at the National Taipei University of Nursing and Health Sciences to determine the association between dietary patterns and chronic diseases using big data analysis.
Research interests
Requirements and details
Senior undergraduate or graduate students with a background in nutrition, medicine, or life science-related fields.
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) | More info |

Mentor profile
Education
Ph.D., Department of Pharmacy
M.S., Department of Pharmacy
B.S., Department of Pharmacy
National Taiwan University, Taiwan
Professional Appointments
2020.08- Associate Professor, Department of Pharmacology, School of Medicine
2016.03-2020.07 Assistant Professor, Department of Pharmacology, School of Medicine
2016.01-2016.03 Postdoctoral Research Fellow, Program for Cancer Molecular Biology and Drug Discovery
Taipei Medical University, Taiwan
Introduction
Dr. Chen received his bachelor’s degree in Pharmacy from National Taiwan University. Following this, he earned his Ph.D. in 2012 from the Pharmacological Institute at National Taiwan University under the supervision of Prof. Che-Min Teng, and continued his postdoctoral research focusing on epigenetic regulation in cancer and the discovery of novel HDAC inhibitors. He then joined Dr. Yun Yen’s laboratory as a postdoctoral fellow to develop novel anticancer agents targeting FGFR signaling pathways. In 2016, Dr. Chen transitioned to an academic role as an Assistant Professor in the Department of Pharmacology, School of Medicine at Taipei Medical University (TMU). Dr. Chen is also the administrative teacher of International Ph.D. Program in Medicine, College of Medicine, TMU.
Professional experience
Professional membership
Training as a pharmacologist, Dr. Chen is dedicated to the research of cancer biology and drug discovery. His work has focused on developing novel therapeutic targets and small molecule compounds for treating bladder cancer. Dr. Chen has identified two therapeutic targets in bladder cancer: PIK3C3 and CK1δ. He has successfully developed MPT0L145, a first-in-class PIK3C3/FGFR inhibitor, which displays promising potential for clinical applications. Dr. Chen has also contributed to the understanding of natural compounds with anticancer properties, such as Cucurbitacin E and Stellettin B, which induce apoptosis and autophagy in cancer cells. Currently, Dr. Chen’s research team also focus on identifying the therapeutic potential and molecular mechanisms of natural products in pediatric high-grade glioma. Dr. Chen’s dedication to research and education continues to inspire students and colleagues alike. His ongoing efforts aim to translate these scientific discoveries into effective clinical treatments for cancer patients. Chen lab welcome potential young scientists to join the research team.
Research interests
Requirements and details
Job Description
Key Responsibilities:
Preferred Intern Educational Level
Required Qualifications
Skill sets or Qualities
Experimental / Wet-lab Skills (Preferred):
Computational / Analytical Skills (if applicable):
Academic & Professional Skills:
Personal Qualities We Value
Expected Outcomes
By the end of the internship, participants are expected to:
• Strengthen experimental and analytical skills in molecular pharmacology
• Gain in-depth understanding of anticancer drug mechanisms
• Develop independence in research planning and execution
• Enhance scientific communication and presentation abilities
• Build strong academic foundations for future PhD or R&D careers
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) | More info |

Mentor profile
Education
Pharm.D.
M.S.
University of Iowa, USA
B.S.
Taipei Medical University, Taiwan
Professional Appointments
2017.05- Professor, Department of Clinical Pharmacy
2012.02-2017.01 Associate Professor, Department of Clinical Pharmacy
Taipei Medical University, Taiwan
Introduction
Dr. Shawn Hsiang-Yin Chen received a bachelor’s degree in Pharmacy from Taipei Medical University (TMU) and completed her M.S. and Doctor of Pharmacy (Pharm.D.) training from the University of Iowa. Dr. Chen had served as the Pharmacy Director at TMU -Wanfang Medical Center for 12 years and the Associate Dean at TMU Office of Global Engagement for 4 years. She is now a Professor and the Associate Dean for Education at TMU College of Pharmacy. Dr. Chen is the founding President of the American College of Clinical Pharmacy (ACCP) Taiwan Chapter. The lab includes presently 5 Ph.D. students (2 international and 3 domestic students), 7 master’s students, 1 statistical research assistant, and many undergraduate students. The lab welcomes international students to explore the possibilities of applying new technologies in clinical pharmacy to extend and excel in our practice.
Research interests
Requirements and details
(1) Medication use data analysis projects:
Data analysis by machine learning methods has been applied to medical and pharmacy research and practice to accelerate the progress with breakthrough results. The adverse drug reactions and treatment success theoretically depend on the patient, diseases, and medications-related features and can be computed to predict the therapeutic outcomes. The traditional statistical model gives us the overall picture of the drug response. The multiple regression analysis employed in epidemiology generates fewer risk factors by reducing the confounding effects than the machine methods. However, machine learning algorithms usually contain abundant features to increase the model performance. The excellent computation capacity of machine learning and deep learning can predict the occurrence of efficacy and adverse drug reactions in patients to help clinical pharmacists provide alternative pharmacotherapy to avoid unwanted effects. A computerized medication management system with machine learning enhancement further helps clinical pharmacists optimize the medication management cycle to ensure better medication safety.
The core abilities of the lab are statistical and machine learning analysis skills. The lab utilizes the principles of pharmacoepidemiology, pharmacogenomics, and pharmacovigilance for managing adverse drug reactions. Applying the epidemiologic risk factor analysis and feature importance analysis in machine learning algorithms helps undermine the complex factorial influences and interactions. A closer examination of the factors at an individual level will reveal a direct picture of why the patient encounters the adverse drug reaction, being able to target and resolve the origins. The team published numerous articles on pediatric medication error prevention, formulary management and cost containment, medication reconciliation, human resource development, pharmacy informatics, and clinical pharmacy service projects to document pharmacists’ value. The lab’s recent focus is using large databases, including Taiwanese and other countries, to analyze and predict adverse drug reactions. Representative publications include statistical and machine learning methods with genetic and non-genetic risk factors to predict cisplatin- or carboplatin-induced nephrotoxicity in lung cancer patients and anti-tuberculosis agents-induced hepatitis.
(2) Innovative education projects
New technologies are important to deliver medication patient education to the target populations in this era. The team extracted the key concepts of Global Initiatives for Asthma (GINA) Guideline and determined the main elements of patient education by expert validation. The Norma Engaging Multimedia Design (NEMD) was applied to develop interactive narratives and serious games to enhance the self-care ability of asthmatic children. The team also published the framework to advise developing serious games for children with chronic diseases. Social media is also an efficient path to facilitate medication education and communication. The team published a clinical trial during COVID period using a commonly used social media in Taiwan, LINE, to educate diabetic patients. The results indicated that social media enhanced the patient’s blood sugar, knowledge, attitude, and health literacy. To advocate extending the frontier
Program Candidates:
(1) Master graduates or undergraduate students in clinical pharmacy programs with statistical knowledge. Those who excel in R or Pythons are preferred.
(2) Master graduates or undergraduate students in bioinformatics programs with undergraduate training in any health care professional programs are welcomed
(3) Master graduates or undergraduate students in statistical or public health programs are welcomed.
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) |

Mentor profile
Education
Ph.D., Institute of Molecular Medicine
Master, Institute of Medical Technology
BS. in Medical Technology
National Taiwan University, Taiwan
Professional Appointments
2021- Associate Professor, Ph.D Program for Cancer Molecular Biology and Drug Discovery
2021- Associate Professor, Graduate Institute of Cancer Biology and Drug Discovery
Taipei Medical University, Taiwan
Introduction
During my postdoc training, I focused on the functions of noncoding RNAs in cancer development. Our work “miR-103/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4.” has been published in 2012 and got 333 citations (Chen et al., Cancer Res. 72:3631-41, 2012.). In 2014, I joined TMU and extended my research to long non-coding RNAs. We used bioinformatic tools to identified some lncRNAs that could contribute to tumor progression and delineate their molecular mechanism by multiple molecular, cellular and in vivo approaches. In 2022, we identified “a novel lncRNA Smyca which coactivates TGF-β/Smad and Myc pathways to drive tumor progression” (Chen et al., J Hematol Oncol. 15:85, 2022.). In this work, we collaborated with Dr. Becky Chen in National Tsing Hua University to develop the “nanoparticle-assisted gapmer antisense oligonucleotides delivery” to target Smyca in vivo. Our result suggests targeting Smyca prevents metastasis and overcomes chemoresistance, therefore provide the preclinical evidence for therapeutic insight of Smyca.
Currently, my lab focuses on three aspects. First, we extend our work on Smyca to dig other therapeutic application. Second, we investigate the roles of interested lncRNAs in tumor progression and their impact on tumor microenvironment. Third, we collaborate with drug delivery team to refine the strategy for lncRNA targeting.
Research interests
Requirements and details
BSc / MSc / PhD in life and biomedical sciences, molecular biology, or biology-related fields.
Skill sets or Qualities
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | More info |
| International Internship Pilot Program, IIPP (NSTC) |
hyichen@tmu.edu.tw

Mentor profile
Education
Ph.D., Pharmacology Institute
National Taiwan University, Taiwan
B.S., School of Pharmacy
Taipei Medical University, Taiwan
Professional Appointments
2023- Professor, Ph.D. Program in Clinical Drug Development of Chinese Herbal Medicine
2023- Professor, Department of Pharmaceutical Sciences
Taipei Medical University, Taiwan
Introduction
Cancer pharmacology encompasses a wide range of therapeutic issues. In the early stages of new drug discovery, translational research has refined the identification of therapeutic targets for clinical relevance and applications. As our understanding of tumor molecular characteristics expands, it becomes more feasible to find existing drugs for drug repurposing or design new drugs that align with these specific characteristics for cancer treatment.
Our training program intends to provide trainees with knowledge of cancer pharmacology, cancer biology, and required lab skills (cell culture, cell viability assays for drug screening, western blotting, flow cytometry analysis, immunofluorescence microscopy analysis) for the understanding of preclinical drug discovery for cancer therapy. We are looking for students who are motivated, ambitious, collaborative, and are interested in doing research with us.
Research interests
As tumor cells tend to escape from apoptosis by upregulating survival signaling or loss of tumor suppressor genes, induction of cell death by novel small molecules or herbal medicine initiates cellular networks and leads to anticancer activity. We are interested in investigating different type of cancer cell death, autophagy, post-translational modifications, cancer metabolism, and DNA damage signaling pathways in cancer cells. Currently, we are particular interested in research new therapeutic targets in pediatric high-grade gliomas (pHGGs) and FGFR3-TACC3 fusion bladder cancers with different approaches to improve the selective cytotoxicity of the drugs used in cancer therapy.
Requirements and details
Preferred Intern Education Level
Individual with a Master’s degree in Life Science, Pharmaceutical Science or Pharmacy.
Skill sets or Qualities
Strong motivation for academic research

Mentor profile
Education
Ph.D. Life Sciences and Institute of Genome Sciences
National Yang-Ming University, Taiwan
M.S. Institute of Microbiology and Immunology
National Defense Medical Center, Taiwan
B.S. Department of Medical Laboratory Science and Biotechnology
China Medical University, Taiwan
Professional Appointments
2020- Associate Professor, Ph.D. Program for Translational Medicine
2020- Associate Professor, Graduate Institute of Biomedical Informatics
2020- Associate Professor, Master Program in Clinical Pharmacogenomics and Pharmacoproteomics
Taipei Medical University, Taiwan
Introduction
Dr. Yi-Fan Chen is an associate professor in Taipei Medical University. Dr. Chen possesses expertise in the fields of Genetics, Geroscience & Geriatrics, and Genetically modified mouse models. When she was a PhD student at National Yang-Ming University, she dedicated herself to the study of aging research. Aging is a progressive functional decline, or a gradual deterioration of physiological function with age, including irreversible age-related process of loss of viability. Exploring a potential strategy to maintain and rejuvenate mitochondrial health is extremely important. She and her mentor, Prof. Ting-Fen Tsai, proposed that Cisd2, a gene with a critical function in modulating health span in mammals, contributes to maintain mitochondrial integrity and functions majorly. Based on this concept, when she started her career at Taipei Medical University, she proposed that an age-dependent decrease of Cisd2 in hair cells and/or auditory nerves leads to age-related hearing loss in mice. This auditory study is being processed for the final mechanism examination. Additionally, they demonstrated that Cisd2 can be a critical target for ameliorating the disease progression of Alzheimer’s disease by maintaining mitochondrial function and integrity .
In recent years, Dr. Chen has a strong passion for investigating stem cells and their surrounding microenvironment. She hypothesizes that controlling the cell fate and stemness of stem cells is highly necessary to prolong the health-span of tissues; otherwise, age-dependently accumulated waste and stress can paralyze the tissue functions. In her lab, they demonstrated that Rrm2b, a critical protein controlling mitochondrial functions, plays an important role in regulating the regeneration capacity of stem cells, resulting in tissue dysfunction and senescence. They pointed out the importance of Rrm2b in myofibers following the investigation of molecular mechanisms in myofiber (part of niche) to modulate the cell fate of muscle stem cells . She believes that establishing mouse models for investigating the relationship between diseases and risk factors is a critical contribution for developing the therapeutic methods. If everyone can follow the principles of 3R, undoubtedly, mouse model will contribute to being a perfect in vivo model.
Aging is a progressive functional decline, or a gradual deterioration of physiological function with age, including irreversible age-related process of loss of viability. In human, several aging-related diseases such as neurodegenerative, cardiovascular diseases, diabetes have endangered human life and affected the life quality. Mitochondria is the energy factory in cell and also play the key role in cellular metabolism. As we known, dysfunctional mitochondria are primary defects in most diseases, especially age associated diseases. To explore a potential strategy to maintain and rejuvenate mitochondrial health is extremely important.
Research interests
Requirements and details
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) |

Mentor profile
Education
Ph.D. (Food and Nutrition Sciences), Florida State University, Tallahassee
Florida, USA
Professional Appointments
2023- Associate Professor, School of Food Safety
2023- Associate Professor, Master Program in Food Safety
2017-2023 Assistant Professor, School of Food Safety
Taipei Medical University, Taiwan
Introduction
Dr. Chen is an Associate Professor in the Department of Food Safety at Taipei Medical University. His research focuses on the biochemical characterization of food allergens and the development of detection platforms, particularly for aquatic products and novel foods such as edible insects. The research goal is to reduce food allergy risks and support the development of safe and sustainable foods.
Our laboratory focuses on food allergen science, food authenticity, and detection method development. We integrate biochemistry, immunology, and food analysis to address important challenges in food safety and risk assessment. Special emphasis is placed on aquatic foods and novel foods, especially edible insects, which are increasingly important in the context of sustainable food systems. Through both fundamental and applied research, we aim to build reliable detection platforms for allergens and adulterants, improve food safety management, and promote consumer protection. Our mission is to advance scientific knowledge, develop practical analytical tools, and contribute to the safe development of future food resources.
Research interests
Requirements and details
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) | More info |

Mentor profile
Education
Ph.D., Department of Biomedical Engineering
National Cheng Kung University, Taiwan
M.S., Graduate Institute of Medical Mechatronics
Chang Gung University, Taiwan
B.S., Department of Biomedical Engineering
I-Shou University, Taiwan
Professional Appointments
2025.08- Assistant Professor, Graduate Institute of Biomedical Materials and Tissue Engineering
Taipei Medical University, Taiwan
Postdoctoral Research Fellow
National Cheng Kung University, Taiwan
2019.01-2020.12 Postdoctoral Research Fellow
Academia Sinica, Taiwan
Introduction
Dr. Ying-Chi Chen is an Assistant Professor at the Institute of Biomedical Materials and Tissue Engineering, Taipei Medical University. He received her Ph.D. training in biomedical engineering-related fields and completed his postdoctoral research focusing on nanomaterials for biomedical applications.
Dr. Chen’s research expertise centers on electron-driven nanomedicine, nano–bio interfaces, and the design of functional nanoplatforms for cancer therapy and disease theranostics. She is particularly interested in understanding how engineered nanomaterials regulate intracellular electron flow, redox balance, and mitochondrial function, and how these mechanisms can be translated into new therapeutic strategies beyond conventional ROS-based approaches.
His work has led to the development of innovative nanoplatforms such as Au@MIL and related hybrid systems, and has been published in high-impact journals. Dr. Chen actively integrates material synthesis, physicochemical characterization, and biological validation to build interdisciplinary research programs.
As a mentor, Dr. Chen values curiosity, independence, and critical thinking. He emphasizes hands-on training, clear communication, and logical experimental design. Students and interns are encouraged to actively participate in discussions, propose ideas, and develop problem-solving skills. His goal is to create a supportive research environment where trainees can build a solid foundation in nanomedicine research and grow into confident young scientists.
YCC’s Lab focuses on the design and development of next-generation nanomaterials for biomedical applications, with particular emphasis on electron-driven nanoplatforms for cancer therapy and disease theranostics. Our research integrates nanomaterial synthesis, surface engineering, and biological evaluation to explore how engineered nanoparticles interact with cellular redox systems, mitochondrial function, and the tumor microenvironment.
One of our core research directions is the development of electron-accepting and electron-regulating nanostructures, such as Au@MIL and related hybrid nanoplatforms, to disrupt cancer cell metabolic homeostasis through an “electron starvation” strategy. By manipulating intracellular electron flow rather than relying solely on reactive oxygen species (ROS) generation, we aim to establish alternative therapeutic paradigms that are effective even in hypoxic and therapy-resistant tumors.
In addition, our lab is expanding toward multifunctional nanomaterials for imaging-guided therapy, including fluorescence, photoacoustic imaging, and SERS-based platforms, as well as nanomedicine applications in immunomodulation and ischemic disease.
Interns in our laboratory will have opportunities to participate in:
We welcome motivated students from chemistry, materials science, biomedical engineering, life sciences, and related fields. Our lab provides a supportive and collaborative environment, and we value curiosity, initiative, and open communication. Through this internship, students are expected to gain hands-on research experience, strengthen scientific thinking, and develop a deeper understanding of interdisciplinary nanomedicine research.
Research interests
Cancer therapy often fails due to tumor hypoxia and adaptive redox responses. Our laboratory focuses on developing electron-driven, biomimetic nanomedicine platforms that reprogram intracellular redox balance and overcome hypoxia-associated therapeutic resistance. By integrating membrane-integrated liposomes (MILs) with functional nanomaterials, we design next-generation therapeutic systems capable of redirecting electron transfer pathways in cancer cells. Our research bridges materials science, live-cell molecular imaging, and translational cancer therapy, aiming to enable effective treatments under clinically relevant conditions.
Requirements and details
Job Description
This internship provides a short-term research opportunity for motivated students to gain hands-on experience in nanobiomaterials, bioimaging, and cellular signaling related to nanomedicine applications. Interns will participate in interdisciplinary projects focusing on the design and biological evaluation of functional nanomaterials for cancer therapy and biomedical imaging. Noted that students who are interested in pursuing their advanced careers or studies here with us will have the priority.
Possible Research Topics
Preferred Intern Educational Level
Junior or senior undergraduate students, and graduate students are all welcome to apply.
Skill sets or Qualities
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) | More info |

Mentor profile
Education
Ph.D., Dept of Nutritional Sciences
M.S., Dept of Nutritional Sciences
University of California, Berkeley, USA
B.S., Dept of Nutrition and Health Sciences
Taipei Medical University, Taiwan
Professional Appointments
2025.06 Acting Director, Master Program in Food Safety
2025.06 Acting Director, School of Food Safety
2023.08-2024.07 Director, Research Center of Food Safety Inspection and Function Development
Taipei Medical University, Taiwan
Introduction
Welcome to the YHC lab, led by Yue-Hwa Chen, at Taipei Medical University, Taipei, Taiwan.
My laboratory mainly focuses on research related to the fields of
Research interests
Requirements and details
Job Description
Observe and/or participate the following research project(s):
Preferred Intern Educational Level
Skill sets or Qualities
Preferred experience(s) or skill(s) as follows:
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) | More info |

Mentor profile
Education
PhD, Department of Mechanical and Electrical Engineering, College of Science and Engineering
National Taiwan Normal University, Taiwan
Master, Department of Mechanical Engineering
Chung Yuan Christian University, Taiwan
Bachelor, Department of Mechanical Engineering
Lung Hwa University of Science and Technology, Taiwan
Professional Appointments
2021.07 Assistant Professor, Institute of Medical Optoelectronics and Mechatronics
Taipei Medical University, Taiwan
2020.12-2021.06 Industry Faculty, Department of Mechanical Engineering
National Taipei University of Technology, Taiwan
2020.12-2021.06 Postdoctoral Researcher, Department of Mechanical and Electrical Engineering
National Taiwan Normal University, Taiwan
Introduction
I received my Ph.D. from the Department of Mechatronic Engineering at National Taiwan Normal University (NTNU). I am currently an Assistant Professor at the Graduate Institute of Biomedical Optomechatronics, Taipei Medical University (TMU). My primary research interests lie in the design and fabrication of electromechanical devices, applied mechanical measurement and analysis, and the integration of advanced pulsed-laser ablation with 3D composite printing technologies for biomolecular and biomedical sensing applications. Recently, my team has focused on developing multi-scale micro/nanostructure fabrication techniques combining laser processing and 3D printing for wearable, non-invasive biomedical sensors aimed at addressing emerging challenges in smart healthcare and precision medicine.
In addition to my research, I have substantial teaching and administrative experience. I have served as a faculty member in a university-level international dual-degree program and have taught EMI (English as a Medium of Instruction) courses. These experiences have provided me with expertise in systematic curriculum planning and cross-cultural academic collaboration. Moreover, I possess industry experience in the machine tool sector, where I was responsible for the design and process optimization of laser hybrid-machining systems. This background enables me to effectively bridge the gap between academia and industry, guiding students to align their research interests with practical industrial needs and fostering interdisciplinary collaboration.
My research team has achieved several notable outcomes, including mentoring international students to secure internships in Taiwan, supporting students in receiving NSTC research project grants, winning national medical engineering competition awards, and earning recognition for conference papers at international venues.
I am a highly motivated and collaborative researcher, dedicated to advancing both teaching and research. I value interdisciplinary teamwork and constructive dialogue to achieve meaningful outcomes. Looking ahead, I aim to cultivate an environment where education and research can flourish synergistically and to attract like-minded students and collaborators to drive innovation in biomedical engineering and related fields.
We focus on the following topics by projects:
Research interests
Requirements and details
Job Description
(SCI publications, research output, and impact)
The internship is research-output–oriented, with strong emphasis on producing high-quality scientific results suitable for publication in SCI-indexed journals (e.g., Sensors and Actuators, Biosensors and Bioelectronics, Applied Surface Science, Ceramics International).
Interns will:
Preferred Intern Educational Level
Applicants should be currently enrolled in or recently graduated from programs related to:
Undergraduate (senior-level), Master’s, or early-stage PhD students are welcome.
Skill sets or Qualities
The ideal candidate should possess some (not necessarily all) of the following skills or qualities:
Additional desired qualities:
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) | More info |

Mentor profile
Education
PhD, Graduate Institute of Nursing, College of Nursing
Taipei Medical University, Taiwan
MS, Institute of Clinical and Community Health Nursing
BS, School of Nursing, National Yang-Ming University
National Yang-Ming University, Taiwan
Professional Appointments
2024.09- Deputy Director, Department of Nursing
Taipei Medical University Hospital, Taiwan
2023.03- Vice Dean, College of Nursing
2022.08- Professor, School of Nursing
Taipei Medical University, Taiwan
Introduction
Professor Hsiao-Yean Chiu is the Director of the School of Nursing, College of Nursing, Taipei Medical University. Her research focuses on evidence-based symptom management and translation research, with particular emphasis on sleep disturbance and delirium. She leads systematic reviews and network meta-analyses to synthesize global evidence and translate findings into practical nursing strategies, care bundles, and decision-support tools, and she has extensive experience leading evidence-based, technology-driven randomized trials and implementation studies to improve patient outcomes. She has been listed among Stanford University’s World’s Top 2% Scientists for five consecutive years and has received multiple multi-year research grants from the National Science and Technology Council (NSTC) of Taiwan.
STEP Lab (Symptom Translation and Evidence-Based Practice Lab) focuses on innovative, evidence-driven symptom management, with an emphasis on sleep disturbance and delirium across diverse clinical settings. Led by Professor Hsiao-Yean Chiu at Taipei Medical University, the lab specializes in conducting systematic reviews and network meta-analyses and translating findings into practical nursing strategies, including care bundles, clinical algorithms, and decision-support tools. STEP Lab is committed to methodological rigor, clinical relevance, and innovation to improve patient outcomes and advance evidence-based practice globally.
Through this three-month international internship, students will join a supportive, interdisciplinary research team and gain hands-on experience in evidence synthesis (from protocol to analysis and reporting), meta-analysis translation, and the development of clinically meaningful symptom management solutions, producing tangible outputs such as a poster, report, or manuscript draft.
Research interests
Requirements and details
Job Description
Responsibilities
Preferred Intern Educational Level
Master’s or PhD students in Nursing
Skill sets or Qualities
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) | More info |

Mentor profile
Education
Ph.D., School of Nursing, College of Nursing
M.S., School of Nursing, College of Nursing
B.S., School of Nursing, College of Nursing
Taipei Medical University, Taiwan
Professional Appointments
2023.09- Director, Service Learning Center
Taipei Medical University, Taiwan
2023.02- Board Member
Taiwan Long Term Care Nurses Association, Taiwan
2022.08- Associate Professor, School of Gerontology and Long-Term Care, College of Nursing
Taipei Medical University, Taiwan
Introduction
Dr. Huei-Ling Chiu is an Associate Professor at the School of Gerontology and Long-Term Care at Taipei Medical University (TMU). Dr. Chiu specializes in dementia care, long-term care, and nursing, with a research focus on enhancing cognitive functions, especially executive function, in older adults. She has been recognized for her excellence in teaching, receiving TMU’s Outstanding Teaching Award.
Her current research projects include:
Dr. Chiu’s work is dedicated to advancing gerontology and long-term care, fostering innovative approaches to improve cognitive health and early detection of cognitive decline in aging populations.
Cognitive Health and Older Adults (CHOA) Associate Professor Huei-Ling Chiu leads a lab from the School of Gerontology and Long-Term Care at Taipei Medical University, Taiwan. The lab focuses on research areas including cognitive function, executive function, dementia-friendly initiatives, rural older adult care, and health promotion. With a background in nursing and experience as an emergency nurse in a medical center, Professor Chiu observed the challenges older adults face in acute medical settings, which inspired her to transition from clinical practice to education and research. Her primary goal is to enhance early intervention and disease prevention among older adults through academic research and educational outreach. The lab is committed to improving dementia awareness, health promotion, and the importance of proactive healthcare in aging populations. The CHOA Lab comprises a diverse team of researchers and students dedicated to advancing the field of gerontology and long-term care. Their collaborative efforts contribute to a deeper understanding of cognitive health in older adults and the development of effective interventions to promote well-being in this population.
In recent years, Dr. Chen has a strong passion for investigating stem cells and their surrounding microenvironment. She hypothesizes that controlling the cell fate and stemness of stem cells is highly necessary to prolong the health-span of tissues; otherwise, age-dependently accumulated waste and stress can paralyze the tissue functions. In her lab, they demonstrated that Rrm2b, a critical protein controlling mitochondrial functions, plays an important role in regulating the regeneration capacity of stem cells, resulting in tissue dysfunction and senescence. They pointed out the importance of Rrm2b in myofibers following the investigation of molecular mechanisms in myofiber (part of niche) to modulate the cell fate of muscle stem cells . She believes that establishing mouse models for investigating the relationship between diseases and risk factors is a critical contribution for developing the therapeutic methods. If everyone can follow the principles of 3R, undoubtedly, mouse model will contribute to being a perfect in vivo model.
Aging is a progressive functional decline, or a gradual deterioration of physiological function with age, including irreversible age-related process of loss of viability. In human, several aging-related diseases such as neurodegenerative, cardiovascular diseases, diabetes have endangered human life and affected the life quality. Mitochondria is the energy factory in cell and also play the key role in cellular metabolism. As we known, dysfunctional mitochondria are primary defects in most diseases, especially age associated diseases. To explore a potential strategy to maintain and rejuvenate mitochondrial health is extremely important.
Research interests
Requirements and details
Job Description
Preferred Intern Education Level
Master’s students or individuals with a master’s degree in healthcare (medicine, nursing, rehabilitation, public health, exercise, etc.) are preferred.
Skill sets or Qualities
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) | More info |

Mentor profile
Education
Ph.D. in Nursing
Vanderbilt University, USA
M.S. School of Nursing
B.S. School of Nursing
National Defense Medical Center, Taiwan
Professional Appointments
2023-present Fellows Ad Eundem of the Faculty of Nursing & Midwifery
Royal College of Surgeons in Ireland (FFNMRCSI), Ireland
2019-Present Fellows
American Academy of Nursing (FAAN), USA
2018-Present Distinguished Professor
Taipei Medical University, Taiwan
Introduction
Dr. Kuei-Ru Chou is a distinguished professor in the School of Nursing, College of Nursing at Taipei Medical University. She has made tremendous contributions to gerontology nursing in practice and evidence-based research working in both public and private institutions for 35 years.
(1) Dr. Chou has conducted research in nursing, gerontology, and mental health making global citizens become more aware of the importance of healthcare providers and the need for nursing research. Dr. Chou’s innovative and outstanding program of healthcare research has had a global reach generating knowledge that has improved the standard of living for patients and caregivers.
(3) Dr. Chou has actively promoted psychiatric home health care and made significant improvements in gerontological psychiatric health care, including the development of dementia care guidelines for older adults. Dr. Chou has also dedicated her efforts to enhancing the training of home healthcare staff as the supervisor of Taiwan’s Home Care and Services Association.
(4) Dr. Chou fostered collaborations with universities in over 48 countries ensuring the global exchange of knowledge and best practices in nursing during her tenure as the Dean of the College of Nursing. She continues to foster global connections as the Dean of the Office of Global Engagement and is currently the President of the Taiwan Sigma Theta Tau Chapter. Through her strong leadership and passionate advocacy, Dr. Chou’s organization has spearheaded the advancement of innovation, quality, and services in long-term care.
(5) Dr. Chou has invested considerable time and energy in mentoring students and new researchers, thus promoting a culture of research and innovation. Her guidance has impacted over 100 graduate students and hundreds of faculty members, leaving a lasting legacy in the nursing community.
Chou’s Lab is an inclusive and integrative lab focused on exploring cutting-edge cognitive training research for mild cognitive impairment and dementia, innovative swallowing function research for presbyphagia and dysphagia, effective and accessible cognitive-behavioral therapy research for patients and caregivers with mental health disorders, and evidence-based research for music and light Therapy.
(1) Cognitive Training Research for Mild Cognitive Impairment and Dementia
Dr. Chou is a pioneer of multi-domain cognitive training research that focuses on interactive cognitive function training and virtual interactive memory training programs which promote and extend the value and knowledge of nursing research. This research promotes and extends the value and knowledge of nursing research on domestic and international levels.
(2) Innovative Swallowing Function Research for Presbyphagia and Dysphagia
Dr. Chou’s dysphagia and dementia research focuses on developing innovative programs that combine different types of swallowing exercises and rehabilitation strategies to improve outcomes and standards of living for older adults and their caregivers.
(3) Cognitive-Behavioral Therapy Research for Patients and Caregivers with Mental Health Disorders
Dr. Chou’s mental health research ensures effective and accessible interventions including cognitive behavioral therapy for patients and caregivers with mental health disorders that improve mental health service access.
(4) Evidence-Based Research for Music and Light Therapy
Dr. Chou’s evidence-based research on music and light therapy provides a platform that facilitates other psychiatric hospitals to adopt music and light therapy as part of mental health care programs.
(5) Mentorship
Dr. Chou facilitates learning using multiple strategies that meet learners’ educational needs, model professional behavior, and stimulate critical thinking, and time management in the lab. Dr. Chou also facilitates learner development and socialization through recognition and adaptation of the unique learning styles of domestic and international masters and Ph.D. students and offers appropriate learner resources, advice, and counselling.
Research interests
Requirements and details
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) |

Mentor profile
Education
Ph.D. in Molecular Biology
M.S. in Biomedical Sciences
National Cheng-Kung University, Taiwan
B.S. in Biology
Kaohsiung Medical University, Taiwan
Professional Appointments
2024.02-2024.03 Acting Director, Graduate Institute of Biomedical Informatics
2022- Professor, International Master Program in Medical Neuroscience
2021- Vice Dean, College of Medical Science and Technology
Taipei Medical University, Taiwan
Introduction
Increasing evidence suggests a link between dysregulation of histone deacetylases (HDACs) activity and many neoplastic/neurodegenerative diseases, as it regulates acetylation of multiple proteins and affects cellular functions, including cell growth, apoptosis, moving, etc. I have been focusing on HDAC research for thirteen years, including postdoctoral research at National Cheng Kung University (2010-2011), postdoctoral research at National Institute on Drug Abuse (2011-2013), and teaching at Taipei Medical University (2013-present). Interestingly, our lab recently discovered that HDACs have completely different functions in promoting cell survival like yin and yang regulation in different cells (Brain tumor cells and nerve cells), and these findings are supported by the following projects.
Research interests
Requirements and details
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) |

Mentor profile
Education
Ph. D. in Chemical Engineering
National Tsing Hua University, Taiwan
Professional Appointments
2023- Professor, Graduate Institute of Biomedical Materials and Tissue Engineering
2020-2023 Associate Professor, Graduate Institute of Biomedical Materials and Tissue Engineering
Taipei Medical University, Taiwan
Introduction
Dr. Chuang is a highly esteemed Professor at the Graduate Institute of Biomedical Materials and Tissue Engineering at Taipei Medical University. He is widely recognized for his expertise across a diverse range of fields, including biomaterials, conductive polymers, orthopedic implants, tumor biology, materials science, chemical compounds, and nanomedicine. His multidisciplinary research integrates these areas to address complex challenges in biomedical engineering, fostering significant advancements in the development of innovative materials and therapeutic technologies.
Dr. Chuang has an impressive body of work, with 75 peer-reviewed publications that span a wide array of academic disciplines. His research contributions have led to the development of novel biomaterials designed to enhance tissue regeneration, improve the biocompatibility of orthopedic implants, and create advanced nanomedicine platforms for targeted cancer therapies. Additionally, his work in conductive polymers has paved the way for innovations in medical devices, while his research in tumor biology has provided new insights into the interaction between materials and cancerous tissues.
Beyond his research, Dr. Chuang’s contributions to the scientific community are reflected in his collaborations with leading experts and institutions. His work not only drives innovation but also deepens the scientific understanding of cutting-edge technologies that have the potential to revolutionize healthcare. His dedication to advancing the field has solidified his reputation as a thought leader in biomedical materials and tissue engineering, making lasting impacts on both academic research and clinical applications.
Welcome to the laboratory of Dr. Er Yuan Chuang at the Graduate Institute of Biomedical Materials and Tissue Engineering, Taipei Medical University. Our lab is at the forefront of multidisciplinary research, specializing in the development and application of advanced biomaterials, conductive polymers, orthopedic implants, tumor biology, materials science, chemical compounds, and nanomedicine. We are dedicated to pushing the boundaries of biomedical research through innovative approaches that address critical challenges in tissue engineering, regenerative medicine, and targeted therapies.
Our lab’s research focuses on the design and synthesis of novel biomaterials to enhance tissue regeneration and improve the biocompatibility and functionality of medical implants. We are particularly interested in the development of conductive polymers for medical devices and nanomedicine platforms that target cancer therapies. Through our work in tumor biology, we seek to uncover new insights into the interaction between innovative materials and cancerous tissues, aiming to improve therapeutic outcomes.
With over 75 peer-reviewed publications, our lab has made significant contributions to advancing the field of biomedical materials and technologies. We collaborate with leading experts and institutions worldwide to drive innovation and translate scientific discoveries into clinical applications. Our ultimate goal is to create groundbreaking materials and technologies that will revolutionize healthcare and improve patient outcomes. We welcome collaboration, innovation, and curiosity in a dynamic environment committed to excellence in research.
Research interests
Requirements and details
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) | More info |

Mentor profile
Education
Ph.D., Institute of Occupational Medicine and Industrial Hygiene
M.S., Institute of Occupational Medicine and Industrial Hygiene
National Taiwan University, Taiwan
Professional Appointments
2020.01- Professor, School of Public Health
2017.02- Professor, Department of Public Health, School of Medicine
2018.04- Professor, Master Program in Applied Molecular Epidemiology
Taipei Medical University, Taiwan
Introduction
I graduated from Institute of Occupational Medicine and Industrial Hygiene, National Taiwan University, where I got a Doctor of Philosophy Degree in Industrial Hygiene in 2006. I have worked as an environmental health and safety consultant in Foundation of Taiwan Industry Service in Taipei, Taiwan, a research fellow in Department of Environmental Health, Harvard School of Public Health, and an assistant professor in Department of Nursing, St. Mary’s Medicine, Nursing and Management College. I am now working as a professor in Department of Public Health, School of Medicine, College of Medicine, Taipei Medical University.
Our lab focuses on intervention studies to reduce air pollution exposure and improve human health. From 2015 to 2020, our lab found that traffic-related fine particles (PM2.5) were associated with autonomic alteration. Commuting modes could modify the effects of PM2.5 on heart rate variability (HRV) indices among young, healthy subjects. The personal exposure levels to PM2.5 were the highest in the walking commuters. The effects of PM2.5 on HRV indices were the lowest in the subway commuters compared to the effects in the walking commuters. For indoor air pollution exposure and human health, our lab found that indoor air pollution exposure was associated with systemic inflammation, oxidative stress and elevated blood pressure. The long-term filtration of indoor air pollution with an air conditioner filter was associated with cardiovascular health improvement of adults. Moreover, our lab found that houseplants could reduce indoor particulate air pollution and improve respiratory health among health adults. However, the presence of houseplants was associated with indoor ozone, isoprene and peak expiratory flow rate variations in the summer. Therefore, we recommend that the indoor temperature should be maintained below 30 degrees Celsius to avoid an increase in ozone concentration. From 2019 to 2022, the coronavirus disease 2019 (COVID-19) outbreak is a public health emergency of international concern. people are racing to buy face masks, especially medical masks to protect themselves from infection. It has led to a medical mask shortage around the world and may result in shortage of medical mask for people in need. Our team investigated whether cotton mask worn by respiratory infection person could suppress respiratory droplet levels compared to medical mask. We found that cotton mask could be a potential substitute for medical mask for respiratory infection person in microenvironment with air conditioning. Healthy people may daily use cotton mask in the community since cotton mask is washable and reusable.
Research interests
Requirements and details
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) | More info |

Mentor profile
Education
Ph.D., Institute of Medical Sciences
Tzu Chi University, Taiwan
M.S., School of Public Health
B.S., School of Nursing, Department of Nursing
National Defense Medical Center, Taiwan
Professional Appointments
2022.09- Director, School of Nursing, College of Nursing
2021- Director, Expanded Active-Ageing Center for Innovative Intelligent Internet Service and Research
2017- Vice Dean, College of Nursing
Taipei Medical University, Taiwan
Introduction
Dr. Min-Huey Chung is a distinguished nursing leader and researcher with extensive expertise in nursing, public health, and mental health care. Currently serving as the Director of the School of Nursing at Taipei Medical University (TMU), she has significantly influenced the academic community at TMU, holding key leadership roles such as Vice Dean of the College of Nursing. With a Ph.D. in Nursing from Tzu Chi University and advanced degrees in Public Health and Nursing, Dr. Chung is dedicated to advancing nursing education, research, and healthcare services.
Her research spans a variety of critical areas, including mental health, sleep disorders, and the integration of artificial intelligence and innovative technologies in healthcare. As the principal investigator of several funded projects, Dr. Chung has developed algorithms and models that aim to improve patient care, particularly in the fields of sleep quality, chronic disease management, and mental health. She has also made substantial contributions to the psychometric validation of scales and the evaluation of health interventions such as yoga and cognitive-behavioral therapy.
Dr. Chung has published extensively in high-impact journals, with numerous studies in SCI and SSCI-indexed journals, and has demonstrated leadership in advancing clinical decision support systems and applying machine learning to medical documentation. Her research has also explored the psychosocial impacts of chronic diseases, acculturation, and stigma, influencing both patient care and healthcare practices.
A renowned member of several nursing organizations, Dr. Chung holds leadership positions within Sigma Theta Tau International and was named a Fellow of the American Academy of Nursing (FAAN) in 2022. Her career is characterized by her ongoing commitment to advancing nursing practice and improving healthcare outcomes through collaborative and interdisciplinary research.
The Evidence-based Translational Research Team (EBTRT) at the Cognitive Behavior and Health Promotion Lab, founded in 2022, is dedicated to advancing evidence-based practices in healthcare, particularly in mental health, psychiatric nursing, sleep disorders, behavioral therapy, and psychopathology. The team aims to bridge the gap between scientific research and clinical application, improving patient outcomes and enhancing mental health services.
Key areas of research include developing new treatment approaches for psychiatric conditions, improving care for high-risk populations, and addressing sleep disorders such as insomnia and sleep apnea. The team also investigates the use of behavioral therapies, such as cognitive-behavioral therapy (CBT) and Acceptance and Commitment Therapy (ACT), to treat mental health conditions like depression and anxiety. Additionally, the EBTRT explores the biological, psychological, and social factors contributing to psychiatric disorders, such as depression and schizophrenia.
The team employs rigorous research methodologies, including systematic reviews, meta-analyses, clinical trials, and large-scale data analysis, to evaluate the effectiveness of various interventions. Their work aims to directly inform clinical practice, ensuring that healthcare providers use the latest evidence-based strategies in treating mental health disorders.
Overall, the EBTRT is making significant contributions to the understanding and treatment of mental health conditions by translating research findings into real-world applications, ultimately improving healthcare outcomes for patients.
Research interests
Requirements and details
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) | More info |

Mentor profile
Education
PhD Biology (specialisation in Neuroscience)
Carleton Univeristy, Canada
MLitt Philosophy
BSc (Hons), Pharmacology
University of Glasgow, UK
Professional Appointments
2021.02- Associate Professor, Graduate Institute of Mind Brain and Consciousness
Taipei Medical University, Taiwan
2014- Adjunct Assistant Professor
Hangzhou Normal University, China
2019.08.15-2021.01 Assistant Professor, Graduate Institute of Mind Brain and Consciousness
Taipei Medical University, Taiwan
Introduction
I am interested in how the brain organises its activity over time to adapt to changing in demands. I then apply these fundamental principles to questions such as how the brain produces consciousness and what changes in the brain of people with psychiatric disorders. To do this work I primarily use different neuroimaging techniques in humans.
Research interests
Requirements and details
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) |

Mentor profile
Education
PhD, School of Public Health, College of Public Health and Nutrition
MNSc, Graduate Institute of Nursing
Taipei Medical University, Taiwan
BNSc, School of Nursing
Hanoi Medical University, Vietnam
Professional Appointments
Introduction
Dr. Duong is currently an Associate Professor of the School of Nutrition and Health Sciences, Taipei Medical University, Taiwan. He has also served as the President of the Asian Health Literacy Association (2025-2026) and the Standing Committee Chair of the International Health Literacy Association, Boston (2025-2027). He has been invited as a Guest Faculty of Tufts University School of Medicine since 2018. He is an active member of several international organizations, e.g. Nutrition Society of Taiwan, the American Society for Nutrition, and others.
As a young professor whose international education and research career has integrated medical and health sciences, public health, and nutrition, he has published more than 70 original research articles in about 35 prestigious international journals. He has served as an editorial board member of Health Promotion International and Scientific Reports, an Associate Editor of Frontiers in Psychology and Frontiers in Nutrition, a Guest Editor of Nutrients, a Guest Advisor of Annals of Medicine, and a reviewer for more than 40 international journals. In addition, he had more than 30 scientific presentations at national and international conferences.
Dr. Duong has received 16 honourable academic awards from national and international organizations from Australia, Indonesia, Malaysia, Switzerland, Taiwan, the United States, Sri Lanka, Thailand, and Vietnam.
He has received several research grants, e.g., one “Grant for newly recruited Faculty” for conducting his ongoing projects, two “Matching Fund” grants for conducting COVID-19-related studies, and two NSTC grants for a project on marriage and the intention and realization of having children among young adults. He also conducted several grant-funded collaborative research projects with partners from Vietnam, Taiwan, Hong Kong, and Israel.
Dr. Duong has developed a strong academic background and a wide international network. He has been closely working with other scholars on several research projects (e.g. Health and dietary literacy, dietary intake and behaviors, mental health and quality of life in hemodialysis, chronic kidney disease, stroke, hypertension, diabetes mellitus, and COVID-19) in Asian countries (Taiwan, Vietnam, Thailand, Indonesia, Malaysia, Kazakhstan, Pakistan, Bangladesh, India, Japan, Hong Kong, Philippines, and Mongolia), and also collaborated with the research consortium in Europe and with growing number of institutions in Australia, United States and Africa.
Lab members are those studying MSc and PhD programs in and out of Taiwan. Some alumni continue to work and publish more papers.
Some outstanding members, among others.
Nguyen Hoang Minh: https://www.researchgate.net/profile/Minh-Nguyen-Hoang
Pham Minh Thu: https://www.researchgate.net/profile/Thu-Pham-48
Dang Thi Loan: https://www.researchgate.net/profile/Loan-Dang-7
Tran Tuan Tu: https://www.researchgate.net/profile/Tran_Tu13
Nguyen Thi Phuong Thao: https://www.researchgate.net/profile/Thao-Nguyen-Thi-Phuong-2
Le Duc Huy: https: //www.researchgate.net/profile/Huy-Le-Duc-3
Nguyen Thi Hong Nhi: https://www.researchgate.net/profile/Nhi-Nguyen-44
Hoang Thi Ngoc Anh: https://www.researchgate.net/profile/Thi-Ngoc-Anh-Hoang
Quach Ha Linh: https://www.researchgate.net/profile/Ha-Linh-Quach
Research interests
Requirements and details
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) | More info |

Mentor profile
Education
Ph.D. Chemistry
Taiwan Normal University, Taiwan
B.S. Chemistry
Tunghai university, Taiwan
Professional Appointments
2022- Director, Master Program in Clinical Genomics and Proteomics
2021- Associate Professor, Master Program for Clinical Pharmacogenomics and Pharmacoproteomics
2021- Associate Professor, Department of Pharmaceutical Sciences
Taipei Medical University, Taiwan
Introduction
Chia-Li Han, Ph.D., is an Associate Professor at Taipei Medical University, where she also serves as Director of the Master Program in Clinical Genomics and Proteomics. She received her doctoral training in analytical chemistry from National Taiwan Normal University and completed postdoctoral research at Academia Sinica, establishing a strong foundation in mass spectrometry, chemical biology, and systems-level protein analysis. Her academic career reflects a steady progression from fundamental analytical innovation to clinically oriented translational research.
Dr. Han is internationally recognized for her contributions to functional proteomics, proteogenomics, and membrane proteomics, with sustained research output spanning lung diseases, cancer biology, immune regulation, and environmental health. She has received multiple young investigator and international conference awards and actively contributes to the global proteomics community as a society board member, invited journal editor, and reviewer for leading journals in analytical chemistry, proteomics, and translational medicine. Her work consistently bridges high-resolution technology development with biologically and clinically meaningful applications.
The Han Laboratory is a translational mass spectrometry and systems biology laboratory focused on elucidating disease mechanisms through integrated proteomic and multi-omic analyses. Building on strong expertise in analytical chemistry and biological mass spectrometry, the lab combines quantitative proteomics with complementary omic layers—including genomics, transcriptomics, metabolomics, and immunopeptidomics—to achieve a comprehensive molecular characterization of complex biological systems. This integrative strategy enables the identification of disease-associated pathways, regulatory networks, and clinically relevant biomarkers.
A central mission of the laboratory is to bridge multi-omic data generation with biological interpretation and clinical translation. Advanced mass spectrometry platforms, data-independent acquisition (DIA) workflows, and computational modeling are employed to ensure scalability, reproducibility, and analytical depth. Through interdisciplinary collaboration and rigorous training, the laboratory provides a research environment that supports innovative discovery at the interface of proteomics, precision medicine, and translational biomedical research.
Research interests
Requirements and details
Job Description
Students will participate in basic laboratory activities and learn how omics technologies are applied to study human diseases. Tasks include sample preparation, literature review, and participation in lab meetings.
Preferred Intern Educational Level
Skill sets or Qualities
Preferred Skills / Background
Qualities
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) | More info |

Mentor profile
Education
Ph.D., School of Nutrition and Health Sciences
MS., School of Nutrition and Health Sciences
Taipei Medical University, Taiwan
Professional Appointments
2023.08- Director, School of Food Safety
2021.08- Associate Professor, Master Program in Food Safety
Taipei Medical University, Taiwan
Introduction
Dr. Hou earned her Ph.D. from the School of Nutrition and Health Sciences at Taipei Medical University in 2012. After completing her postdoctoral training at National Taiwan University Hospital, she joined the faculty at Taipei Medical University in 2016. Currently, Dr. Hou serves as an Associate Professor and Chair of the School of Food Safety and the Master Program in Food Safety at Taipei Medical University. With extensive experience in laboratory management, she also acts as an accreditation auditor for food analysis laboratories. Her research focuses on innovative approaches to understanding the connections between diet and inflammatory diseases.
The research in our lab mainly focuses on food toxicology and immunonutrition. We primarily utilize disease animal models and cell culture models to investigate the effects of food contaminants or nutrients on the immune system. Students can acquire core techniques such as flow cytometry and molecular biology experiments.
Research interests
Requirements and details
Preferred Intern Education Level
Skill sets or Qualities
Preferred hard skills:
Soft skills:
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) | More info |

Mentor profile
Education
PhD, International Business
National Taiwan University, Taiwan
M.S., Institute of Technology Management
National Tsing Hua University, Taiwan
B.S., School of Pharmacy
Taipei Medical University, Taiwan
Professional Appointments
Taipei Medical University, Taiwan
Introduction
Dr. Jason Hsu is an expert in digital health, real-world data (RWD), and real-world evidence (RWE) in the medical field. He is currently an Associate Professor in the International Ph.D. Program in Biotech and Healthcare Management at the College of Management, Taipei Medical University (TMU). Dr. Hsu holds multiple leadership positions related to health data research, including Director of the Clinical Data Center at TMU, Director of the Research Center for Health Industry Data Analytics at the College of Management, Director of the Clinical Big Data Research Center at TMU Hospital, and President of the Taiwan Observational Health Data Sciences and Informatics Society (OHDSI Taiwan Society). He received training at Harvard Medical School and has led numerous large-scale RWD/RWE projects. Dr. Hsu’s mission is to advance digital medicine, precision therapy, and biotech healthcare management through global RWD/RWE collaboration. (Personal website: https://jasonchsu-lab.com/)
Research interests
Big Data Analysis and Research Methodology
Requirements and details
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) | More info |

Mentor profile
Education
Ph.D., Institute of Bioinformatics and Systems Biology
Master, Institute of Bioinformatics
B.S., Department of Biological Science and Technology
National Chiao Tung University, Taiwan
Professional Appointments
2022- Professor, Master Program in Clinical Genomics and Proteomics
2022- Professor, International Ph.D. Program for Translational Science
Taipei Medical University, Taiwan
Introduction
Dr. Kai-Cheng Hsu obtained his Ph.D. degree under Professor Jinn-Moon Yang in 2011. He completed his post-doctoral fellowship training under Professor Jinn-Moon Yang, where he designed software and proposed novel strategies for drug design. He then completed an assistant research fellowship at the Center for Bioinformatics Research at National Chiao Tung University. Next, He joined Taipei Medical University in 2015 as an assistant professor and received a promotion to professor in 2022.
Dr. Hsu ‘s research interests include drug discovery and rational drug design. He developed new tools for protein-ligand docking, virtual screening, and lead optimization, such as iGEMDOCK and SiMMap. Dr. Hsu also proposed pathway-based screening strategies for multitarget inhibitors of diverse proteins in metabolic pathways and a parallel screening strategy of wild-type and drug-resistant targets for anti-resistance inhibitors. Incorporating new tools and strategies, his team has identified 60 novel inhibitors targeting various proteins. Currently, his lab focuses on designing new kinase inhibitors for cancer and neuro disorders. His team has identified novel inhibitors targeting 80 kinases, 20 of which inhibit the targeted kinases within <10 nM. His work has been published 95 papers in various SCI journals and yielded 3 patents. Traditional small-molecule drug development requires immense financial resources and extensive time commitment. Unfortunately, these requirements are coupled with a low success rate. Establishing an artificial intelligence (AI) platform for drug design has the potential to reduce the demanding development time and cost seen in traditional drug development pipelines. Our team has developed an AI platform for drug design and discovery. The platform establishes various models targeting the four phases of drug development: (1) Hit identification; (2) Lead optimization; (3) Cytotoxicity prediction; and (4) ADME prediction. In hit identification, the platform has various models that can predict potential inhibitors for protein kinases with an average accuracy of 85%. For lead optimization, the platform designs one million compound derivatives and selects the most promising derivatives for synthesis. 12 cancer cell models have been established to predict compound cytotoxicity with an average accuracy of 90%. Finally, the platform for the ADME prediction phase can predict a compounds’ ability to pass the blood-brain barrier with an accuracy of 96%. Our platform can also predict acute toxicity, immunotoxicity, and mutagenicity with an accuracy of 83.8%, 84.2%, and 84%, respectively. Our work has yielded novel nanomolar inhibitors targeting 80 kinases, 20 of which inhibit the targeted kinases with IC50 values of <10 nM. We believe that our platform can accelerate different stages of drug development, reduce costs, and increase the success rate for new drugs. [/av_toggle] [av_toggle title='Research interests' title_open='' tags='' title_pos='' slide_speed='' custom_id='' aria_collapsed='' aria_expanded='' av_uid='av-28lae2i' sc_version='1.0']
Requirements and details
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) |

Mentor profile
Education
Fellowship training
Washington University School of Medicine, USA
M.D, School of Medicine
Taipei Medical College, Taiwan
Professional Appointments
2024.04- Dean, College of Medicine
2024.04- Professor, Graduate Institute of Medical Sciences
Taipei Medical University, Taiwan
Introduction
Dr. Chaur-Jong Hu is the consultant of the Dementia Center in Taipei Medical University-Shuang Ho Hospital, New Taipei City, Taiwan. He is also a professor in Neurology and the Dean of the College of Medicine, Taipei Medical University, Taipei, Taiwan.
Dr. Hu obtained his medical degree from Taipei Medical University, Taipei, Taiwan in 1990. He completed the residency training in the Department of Neurology, Taipei Municipal Jen-Ai Hospital. He also has ever worked as a research fellow in the Department of Neurology, stroke center, Washington University School of Medicine, St. Louis, Missouri, USA. He established a laboratory focusing on molecular mechanisms of neurological diseases, including cell and animal researches in TMU campus. Dr Hu has extensive experience in global and domestic clinical trials of therapies for stroke, Alzheimer Disease and other neurological diseases. He has published over 250 peer-reviewed papers and 2 book chapters on the pathophysiology of ischemic injury of brain and use of botulinum toxin in neuropathic pain.
Dr Hu is currently the executive supervision and ex-president of the Taiwan Neurological Society and ex-president of Taiwan Dementia society. He is also a fellow of the American Heart Association (FAHA) and President of Vas-Cog Asia.
We are working on molecular mechanisms of neurological diseases, more focusing on Alzheimer disease (AD) and vascular dementia (VaD). In our Lab., we have transgenic AD mouse model and VaD moue model by bilateral common carotid artery occlusion (BCCAO). We are trying new approaches for therapy. In addition, we have established one cohort of dementia and one cohort of post-stroke cognitive impairment. There are 4000 and over 500 patients in the cohorts respectively. The methodology in our Lab includes molecular biology, such as Western blotting, real time RNA, DNA genotyping, flow cytometry and single cell RNAseq, animal MRI, PET imaging.
Research interests
Requirements and details
Preferred Intern Education Level
Medical students
Skill sets or Qualities
Medical knowledge and basic skills of molecular biology
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) |

Mentor profile
Education
Ph.D. The Institute of Basic Medical Science
M.S. Department Of Pharmacology
National Cheng-Kung University
B.A. School of Pharmacy
Taipei Medical University, Taiwan
Professional Appointments
2019- Associate Professor, The Ph.D. Program for Neural Regenerative Medicine
2014- Department of Pharmacology, College of Medicine
Taipei Medical University, Taiwan
Introduction
Dr. Huang is an University Associate Professor in Ph.D. Program in Medical Neuroscience at Taipei Medical University. After she graduated from Taipei Medical University, she got the pharmacist license and involved in the research about the pharmacology and molecular mechanism of cervical cancer during her master and Ph. D. research in National Cheng-Kung University. In her postdoctoral fellow in Academia Sinica, she was interested in neurodegenerative diseases, and focused on studying the pathological protein TDP-43 in both frontotemporal lobar degeneration (FTLD) with ubiquitin inclusions (FTLD-U) and amyotrophic lateral sclerosis (ALS). Now she is an associate professor in Taipei Medical University, and she continues her interest in exploring more molecular mechanism of TDP-43 in neural-related diseases.
Our previous studies focused on identifying the physiological function and neuropathies of the neurodegenerative disease-related pathological TDP-43. Also, we endeavor to explore potential therapeutic strategy specifically targeting on ameliorating TDP-43-related proteinopathies. Unrevealing these underlying mechanism is thus essential to provide more comprehensive understanding about TDP-43 neuropathies.
TDP-43: TDP-43 is identified as the major component of the ubiquitin positive inclusion in the frontotemporal lobar degeneration (FTLD-U) and amyotrophic lateral sclerosis (ALS) neurodegenerative diseases, suggesting the mismetabolism of TDP-43 protein is the major cause for the pathological TDP-43 aggregates formation. However, the comprehensive picture of the metabolism and mis-metabolism of TDP-43 protein itself in normal cells remains unclear. We provide a comprehensive model of the metabolism and mismetabolism of TDP-43 in relation to these findings is presented in J. Cell. Sci. 2014. In addition, we also discovered the impact of loss-of-function of TDP-43 on autophagy regulation which contributes to the development of TDP-43 proteinopathies. Our works was presented in J. Biol. Chem. 2011. We also explore the detailed therapeutic mechanism of traditional herb medicine berberine on TDP-43 proteinopathy which provides an candidate drug targeting with less side effect potentially developed as an alternative therapy for TDP-43-related neuropathology in FTLD and ALS (J Biomed Sci, 2016) (104-2320-B-038-054-MY3). Moreover, we have identified Znf179 as an E3 ubiquitin ligase for TDP-43 and demonstrated the ZNF-179-mediated regulatory mechanism in TDP-43 metabolism and TDP-43-related proteinopathies. A better understanding of the function of the novel E3 ligase, Znf179, and the correlation between Znf179 and TDP-43 will provide a new therapeutic avenue for the ALS and FTLD-U patients in the future (J Biomed Sci, 2018)(104-2320-B-038-054-MY3). In clinical trial, we have demonstrated the elevation of plasma TDP-43 in the exosome may develop as a potential biomarker for the diagnosis of ALS patients (J. Neurol. Sci. 2020). Moreover, in our phase II clinical trial, we found that the add-on therapy of tamoxifen mildly attenuates the disease progression in the first 6 months, implicating the benefit role of tamoxifen for the early disease onset ALS patients (Medicine, 2020). Not only in FTLD and ALS, we discovered that TDP-43 also plays a role in ischemia stroke and involved in rapamycin-mediated therapeutic effect in ischemia stoke disease model (Int J Mol Sci. 2022)(110-2320-B-038-067-MY3). To explore the specific way to target TDP-43 for proteasome degradation, we dedicated to unravel the role of TNKS-mediated ADP-ribosylation of TDP-43 and TNKS-PI31 signaling cascade for the activity regulation and axonal transportation of 20S proteasome under normal condition and TDP-43-related neuropathies (Manuscript is in preparation) (110-2320-B-038-067-MY3). Overall speaking. we provide a better understanding of the TDP-43 proteinopathies and open a new therapeutic avenue for ALS and FTLD-U patients.
Research interests
Requirements and details
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) |

Mentor profile
Education
Ph.D., Graduate Institute of Biomedical Informatics
M.S., Graduate Institute of Biomedical Informatics
B.A., School of Healthcare Administration
Taipei Medical University, Taiwan
Professional Appointments
2025- Research Fellow, International Research Center for Health Information Technology, School of Medical Science and Technology
2023- Adjunct Assistant Professor, Graduate Institute of Biomedical Informatics
2022-2025 Associate Research Fellow, International Research Center for Health Information Technology, School of Medical Science and Technology
Taipei Medical University, Taiwan
Introduction
Dr. Chih-Wei (Grace) Huang graduated from the Doctoral Program in Medical Informatics at Taipei Medical University in 2016 and served as a full-time Assistant Research Fellow at the International Research Center for Health Information Technology of the College of Medical Science and Technology, Taipei Medical University since 2018. Dr. Huang was promoted to Associate Research Fellow in 2022. To date, Dr. Huang has published 43 SCI/EI journal papers, with 6 as the first or corresponding author, and has participated in over 30 funded projects (including research, industry-academic collaborations, and scientific innovation projects), serving as the principal investigator for 3 of these projects. Dr. Huang has also been involved in over 10 patent applications, co-inventing 2 patents (applications in Taiwan and the U.S. for invention patents and a new type of patent in Taiwan). In 2020, Dr. Huang was appointed as a startup consultant for the SPARK program at Taipei Medical University and established the Digital Health Translation (DHT) initiative to assist with field validation and clinical data verification, linking resources for industry talent training and industry-academic collaboration platforms.
Dr. Huang’s research focus is on “Digital Health Care for Chronic Kidney Disease,” with doctoral research on “Visualizing Disease Trajectories through Big Data” focusing on chronic kidney disease, Taiwan’s new national disease. In collaboration with Professor Kuan-liu Ma from the Data Visualization Center at the University of California, Davis, this work utilized time-series, multi-dimensional big data analysis, and interactive information visualization systems to track the disease progression of a research cohort over 13 years, providing researchers and clinicians with new perspectives and evidence for precise prevention and care. Subsequently, Dr. Huang has continued to delve into applying data analysis and machine learning for the prevention of comorbidities in chronic kidney disease and dialysis patients, drug dosage recommendations, personalized health education information, and wearable device interventions. The project titled “Constructing an Intelligent Erythropoiesis-Stimulating Agent Dosing Model for Patients with Chronic Kidney Disease Using Electronic Medical Records and Personal Health Information” received consecutive funding for two years (2019 and 2020) from the Ministry of Science and Technology (MOST 108-2410-H-038-010-SSS, 109-2410-H-038-007-), utilizing retrospective data (from Wanfang Hospital, Taipei, Tunghai Hospital, Taichung, and the Clinical Data Database of Taipei Medical University) and deep learning to establish an intelligent dosing prediction model. Furthermore, aiming to further construct personalized health education models through behavioral science to enhance patients’ health literacy and disease awareness, Dr. Huang supervised two students from the Department of Gerontological Health Management in obtaining the Ministry of Science and Technology undergraduate project grants in 2021 and 2022, with projects titled “Health Literacy and Smart Bracelet Intervention as Important Factors and Preliminary Exploration of the Effects on Physical Activity of Elderly Dialysis Patients in Taiwan (NSTC 110-2813-C-038-199-H)” and “Evaluating the Effectiveness of Personalized Health Education Information Delivery via the LINE Platform for Middle-aged and Elderly Dialysis Patients (NSTC 111-2813-C-038-013-H),” leading to the presentation of research results at international academic conferences and receiving honors. Currently, Dr. Huang is working on the project “Developing a Multimodal Personalized Osteoporosis Fracture Risk Prediction Model for Dialysis Patients Using Clinical Phenotypes and Wearable Physiological Measurement Data (NSTC 112-2410-H-038-011-),” aiming to establish a personalized fracture risk prediction and assessment tool through multicenter clinical databases and field case collection, with clinical validation expected.
Research interests
Requirements and details
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) | More info |

Mentor profile
Education
Ph.D., Graduate Institute of Nursing, College of Nursing, Taipei Medical University
Taipei Medical University, Taiwan
M.S., School of Nursing
B.S., School of Nursing
National Taipei University of Nursing and Health Sciences, Taiwan
Professional Appointments
2023.08- Professor, School of Nursing, College of Nursing
2019.02-2023.08 Associate Professor, School of Nursing, College of Nursing
2017.09-2019.01 Assistant Professor, School of Nursing, College of Nursing
Taipei Medical University, Taiwan
Introduction
Hui-Chuan Huang is a Professor and Deputy Head of the School of Nursing at Taipei Medical University. Her research focuses on geriatric nursing, with particular emphasis on frailty and sarcopenia, dementia care, and health promotion among aging populations. She is dedicated to developing innovative, evidence-based interventions to improve functional outcomes, cognitive health, and quality of life in middle-aged and older adults.
Dr. Huang’s work integrates gerontechnology and digital health approaches, including virtual reality (VR) and mobile health (mHealth), to advance person-centered and technology-assisted care models. Her research also explores the role of oral health in systemic health and aging-related outcomes.
Methodologically, she has extensive expertise in advanced quantitative research, including randomized controlled trials, systematic reviews, and network meta-analyses. Over the past years, she has led multiple nationally funded research projects and published extensively in SCI/SSCI journals.
Through interdisciplinary collaboration, Dr. Huang aims to generate high-quality evidence that informs clinical nursing practice, enhances health promotion strategies, and supports the development of sustainable care models for aging societies.
Gerontechnology Health Promotion Lab focuses on advancing innovative, technology-enhanced approaches to promote healthy aging and improve the quality of life among middle-aged and older adults. The lab integrates gerontechnology, digital health, and nursing science to develop, implement, and evaluate interventions targeting cognitive function, physical health, and psychosocial well-being.
Our research emphasizes the application of emerging technologies, including virtual reality (VR) and mobile health (mHealth), to support dementia care, frailty prevention, oral health, and chronic disease management. We aim to design evidence-based, patient-centered interventions that are feasible for clinical and community settings.
In addition, the lab is committed to strengthening nursing roles in digital health by developing AI-assisted assessment tools, enhancing health literacy, and promoting self-management behaviors. Through interdisciplinary collaboration and rigorous research methodologies, including randomized controlled trials and meta-analyses, we strive to generate high-quality evidence that informs clinical practice, health policy, and sustainable care models for aging populations.
Research interests
Requirements and details
Job Description
Preferred Intern Educational Level
Skill sets or Qualities
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) | More info |

Mentor profile
Education
Ph.D., Department of Pharmacy
M.S., Department of Pharmacy
National Taiwan University, Taiwan
B.S., School of Pharmacy
Kaohsiung Medical University, Taiwan
Professional Appointments
Researcher, Department of Medical Research
Taipei Medical University Hospital, Taiwan
2023.02- Associate Professor, Department of Pharmacology, College of Medicine
2018.08-2023.01 Assistant Professor, Department of Pharmacology
Taipei Medical University, Taiwan
Introduction
Welcome to the Vascular Pharmacology and Innovative Drug Discovery Laboratory at Taipei Medical University. I am Shiu-Wen Huang, an Associate Professor in the Department of Pharmacology. My academic journey began with a B.S. in Pharmacy from Kaohsiung Medical University, followed by an M.S. and Ph.D. from National Taiwan University. Before transitioning into full-time academia and research, I served for nearly a decade as a clinical pharmacist at National Taiwan University Hospital, an experience that deeply informs my commitment to translational medicine. My research program is dedicated to bridging the gap between basic molecular science and clinical therapy. Our laboratory is particularly interested in the complex mechanisms of vascular remodeling and angiogenesis. We specialize in identifying how novel natural compounds can be leveraged to treat significant clinical challenges, such as restenosis following coronary interventions and tumor metastasis.
Our laboratory, located within the Department of Pharmacology at Taipei Medical University, is dedicated to the discovery and characterization of novel therapeutic agents derived from natural products for cardiovascular diseases and cancer. Our research bridges clinical pharmacy and molecular pharmacology to address critical gaps in current medical treatments
Research interests
We investigate novel benzimidazole derivatives, such as nstpbp5185, which act as dual antagonists of the PDGF and TXA2 signaling axes. This project focuses on how these compounds prevent restenosis after vascular injury by suppressing the redox-sensitive PDGFRβ axis and reducing oxidative stress in vascular smooth muscle cells. Our team also explores the therapeutic potential of natural plant-derived compounds in inhibiting the formation of new blood and lymphatic vessels. Interns will study how these agents modulate VEGFR-2 or VEGFR-3 signaling to suppress tumor growth and prevent metastasis, providing a foundation for next-generation cancer therapies.
Requirements and details
Job Description
Preferred Intern Educational Level
Skill sets or Qualities
Scholarship availability
| Taiwan Experience Education Program, TEEP (MOE) | |
| International Internship Pilot Program, IIPP (NSTC) | More info |
International Internship Pilot Program
(IIPP)
• Undergraduate and graduate students enrolled at foreign colleges and universities
• Foreign nationality
• Academic focus aligns with Taiwan’s national key science & technology fields including humanities and social sciences
28 – 90 days
NT$1,000 (Approximately USD 30) per day
Please note that acceptance into the TRI Program does not guarantee selection for the IIPP scholarships. Scholarship decisions are made independently by the IIPP administrators and are subject to their review process and criteria. Please apply for IIPP scholarships through their official website: https://iipp.tw/
Taiwan Experience Education Program
(TEEP)
• At least having a high school level diploma or above.
• A university student enrolled in a bachelor’s, master’s, or doctoral program, or a recent graduate, except for Ph.D. holders.
• Applicants who are not currently studying in Taiwan, including as degree-seeking or exchange students.
• Having a nationality other than the Republic of China (Taiwan) or the People’s Republic of China.
2 – 6 months
NT$12,000-15,000 per month
Please note that acceptance into the TRI Program does not guarantee selection for the TEEP. Scholarship decisions are made independently by the Host PI and are subject to their review process and criteria. Please apply for TEEP scholarships through the TMU Experience Program Application Form: https://form.jotform.com/212271642480450
Application fee: NT$ 3,750 per application
Access card: NT$ 500 per card
Program fee: basic fee (up to NTD 20,000 per month per program), plus additional program fee (according to the host mentor’s program)
Expenses for paid examinations required to access the laboratories, as per regulations, are not included in the above-mentioned fees.
Please note that additional expenses charged by other facilities on campus are not included in the above-mentioned fees.
Please contact the International Foundation Program (ogeirs@tmu.edu.tw) at the Office of Global Engagement for a separate quotation if you are also interested in enrolling in credit-based or language courses.
Please note that personal expenses such as meals, accommodation, travel insurance, and transportation are not included in the program fee unless otherwise specified.
1. Applicants who register as an undergraduate student
2. Applicants who do not hold a Ph.D. degree nor currently register as a Ph.D. student
Term:2-6 months
Applications accepted:Until October 15, 2026
The application deadline may vary between programs, pelease also refer to the course profile for details.
The first day of your internship should be Monday.
Applicants should submit their application at least 2 months before their intended starting date of the program.
Workflow
(1) Applications submitted through the online application form
(2) Eligibility review by the University Program Coordinator
(3) Professional background review by the hosting Principal Investigator
(4) Online interview hosting Principal Investigator
(5) Confirm package, curriculum, and sign the “SHORT-TERM PROGRAM PARTICIPATION AGREEMENT”
(6) Complete payment
(7) Confirm payment received
(8) Official documents provided to the student
Taipei Medical University (TMU), established in 1960, is home to 11 colleges, one general education center, and over 6,000 students, with more than 49,000 alumni around the world. TMU boasts six affiliated hospitals, including TMU Hospital, Taipei Municipal Wanfang Hospital, Shuang Ho Hospital, Taipei Cancer Center, Taipei Neuroscience Institute, and Hsin Kuo Min Hospital. Together, the hospitals host 3,000 beds and over 9,000 faculty and staff members.
Our mission at TMU is to educate biomedical talents with humanity, innovation, and global vision. We strive to develop a comprehensive education system integrating teaching, research, industrial collaboration, and medical care.


Taipei is the capital city of Taiwan. With its busy shopping streets and contemporary buildings, Taipei serves as the island’s financial, cultural and governmental center. The skyline is crowned by the bamboo-shaped Taipei 101 skyscraper, with upscale shops at the base and a rapid elevator to an observatory near the 508-meter top.
The downtown area offers enjoyable contrasts, with the west side’s narrow streets and street vendors showing Taipei’s past. The city’s east side is now its financial and commercial center, with the Xinyi District’s malls and nightlife representing the city’s metamorphosis into a modern international city.
The information provided, including pricing, is solely for informational purposes and is subject to change without notice.
Ms. Nono Ke ogeirs@tmu.edu.tw
Xinyi Campus ext.2694

QUICK LINKS
Inbound Student
TMU Partners
Academic Alliance
TMU Spotlight
DOWNLOAD
Regulations & Forms
You can see how this popup was set up in our step-by-step guide: https://wppopupmaker.com/guides/auto-opening-announcement-popups/
